Carbapenem-resistant organisms
From IDWiki
Background
- Mechanisms include decreased expression of porins, increased expression of efflux pumps, and carbapenemases
Management
Antibiotic | KPC | NDM | OXA-48 | CRPsA | CRAcB | Stenotrophomonas |
---|---|---|---|---|---|---|
aztreonam-avibactam | + | + | + | ± | – | + |
cefiderocol | + | + | + | + | + | + |
ceftazidime-avibactam | + | – | + | ± | – | – |
ceftolozane-tazobactam | – | – | – | ± | – | ± |
eravacycline | + | + | + | – | + | + |
fosfomycin | ± | ± | ± | ± | – | – |
imipenem-relebactam | + | – | ± | + | – | – |
meropenem-vaborbactam | + | – | – | – | – | – |
plazomicin | + | ± | + | ± | – | – |
colistin | ± | ± | ± | ± | ± | ± |
tigecycline | + | + | + | – | + | + |
References
- ^ Mical Paul, Elena Carrara, Pilar Retamar, Thomas Tängdén, Roni Bitterman, Robert A. Bonomo, Jan de Waele, George L. Daikos, Murat Akova, Stephan Harbarth, Celine Pulcini, José Garnacho-Montero, Katja Seme, Mario Tumbarello, Paul Christoffer Lindemann, Sumanth Gandra, Yunsong Yu, Matteo Bassetti, Johan W. Mouton, Evelina Tacconelli, Jesús Rodríguez-Baño. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clinical Microbiology and Infection. 2022;28(4):521-547. doi:10.1016/j.cmi.2021.11.025.